Inlay

Profile

The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @idsainfo.bsky.social

Clinical Infectious Diseases

Further unraveling the association between HIV, immune suppression, and cancer survival ✅ Just Accepted 🔗 https://bit.ly/4vGiXKk

Don’t Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV ✅ Just Accepted 🔗 https://bit.ly/3RXJXXg

More Attention on Infection-Associate Chronic Conditions Requires Restoring Support for Long COVID ✅ Just Accepted 🔗 https://bit.ly/4vIpkwU

Can Influenza Virus Cause Bacteremia, Sepsis, and Septic Shock? ✅ Just Accepted #IDTwitter 🔗 https://bit.ly/4usrnEj

What if Goldilocks Had a Choice? Rethinking the Optimal Duration of Empiric Antibiotics in Pediatric Hematopoietic Cell Transplant Recipients with Persistent Fever and Neutropenia ✅ Just Accepted 🔗 https://bit.ly/4v3mZww

Use of Dolutegravir for treatment of HTLV-1 ✅ Just Accepted #IDTwitter 🔗 https://bit.ly/4uP9CQh

The latest CID supplement issue highlights the clinical and research framework needed to combat antimicrobial resistance and accelerate progress in antibiotic development. ↪️ https://bit.ly/4xgx8r2

Use of dolutegravir to treat people living with HTLV-1-associated myelopathy (HAM) ✅ Just Accepted 🔗 https://bit.ly/4erBxjx

Early Discontinuation of Empiric Antibiotics in Pediatric Haploidentical Hematopoietic Cell Transplant Recipients with Febrile Neutropenia ✅ Just Accepted https://bit.ly/4umVnBd

Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa ✅ Just Accepted https://bit.ly/4vPAgJa

Clinical Infectious Diseases

In clinically stable children, adolescent and young adult haploidentical hematopoietic cell transplant recipients with febrile neutropenia, early antibioti

bit.ly

Early Discontinuation of Empiric Antibiotics in Pediatric Haploidentical Hematopoietic Cell Transplant Recipients with Febrile Neutropenia

Liraglutide for Obesity in HIV (LIROH) is among the first clinical trials of GLP-1 therapies in Southern Africa and demonstrates that this class has effica

bit.ly

Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa